Related Experiment Videos

Exacerbation of human immunodeficiency virus infection in promonocytic cells by bacterial immunomodulators

K N Masihi1, W Lange, B Rohde-Schulz

  • 1Robert Koch Institute, Federal Health Office, Berlin, F.R.G.

Insights

Bacterial immunomodulators can increase HIV replication in infected monocytes. This study found that components from bacterial cell walls boosted HIV p24 antigen production, linked to altered cytokine levels.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • HIV-infected individuals frequently develop bacterial infections.
  • Monocyte-macrophage lineage cells combat bacteria but can be infected by HIV.
  • Bacterial components can modulate immune responses.

Purpose of the Study:

  • To investigate the effects of bacterial immunomodulators on HIV-infected promonocytic U937 cells.
  • To understand how bacterial components influence HIV expression in monocytes.

Main Methods:

  • Treatment of U937 cells (a human promonocytic cell line) with HIV.
  • Exposure of HIV-infected U937 cells to synthetic muramyl peptide, mycobacterial trehalose dimycolate, and detoxified endotoxin.
  • Measurement of HIV p24 antigen production, interleukin-1 beta (IL-1β), and tumor necrosis factor-alpha (TNF-α) levels.

Main Results:

  • Bacterial immunomodulators initially reduced, then rapidly increased HIV p24 antigen production.
  • Upregulation of HIV expression correlated with increased IL-1β levels.
  • A decrease in TNF-α production was observed alongside enhanced viral expression.

Conclusions:

  • Bacterial immunomodulators can exacerbate HIV replication in infected monocytes.
  • The interplay between bacterial components, monocyte infection, and cytokine production impacts HIV pathogenesis.
  • Further research is needed to explore therapeutic strategies targeting this interaction.

Related Concept Videos